Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Phase Ii Randomized Trial of 41.4 Gy Vs. 50.4 Gy in Neoadjuvant Chemoradiotherapy for Resectable Esophageal Cancer
Ali Kazemian
Ali Kazemian

Associate Professor of Radiation Oncology

Department Radiotherapy

School of Medicine

Imam Khomeini Hospital Complex,Cancer Institute

Radiation Oncology Research Center

Tehran University of Medical Sciences

All Documents
21. Assessing the Willingness of Patients’ Companions to Disclose Bad News to Cancer Patients, Journal of Medical Ethics and History of Medicine (2022)
29. Management of Bulky High-Grade Pleomorphic Sarcoma Using Grid Therapy Technique, International Journal of Radiation Research (2021)